Concepedia
Statistics
Publications
42
Citations
2.3K
H-Index
27
Active since
1996
Affiliations
Abbott Fund(Current)
Abbott (United Kingdom)
Biogen (United States)
Abbott (United States)
Nanjing Medical University
Zhili Xin is an author at Abbott Fund specializing in pharmacology, medicinal chemistry, and drug discovery.
Publications per year
1996–2024
Discovery of a Potent, Selective Protein Tyrosine Phosphatase 1B Inhibitor Using a Linked-Fragment Strategy
Bruce G. Szczepankiewicz, Gang Liu, Philip J. Hajduk et al. · Journal of the American Chemical Society · 2003 · 228 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +17
LncRNA NEAT1 controls the lineage fates of BMSCs during skeletal aging by impairing mitochondrial function and pluripotency maintenance
Hengguo Zhang, Rongyao Xu, Bang Li et al. · Cell Death and Differentiation · 2021 · 181 citations · Full text
Life Sciences, Cell Biology, Genetics +17
Fragment Screening and Assembly: A Highly Efficient Approach to a Selective and Cell Active Protein Tyrosine Phosphatase 1B Inhibitor
Gang Liu, Zhili Xin, Zhonghua Pei et al. · Journal of Medicinal Chemistry · 2003 · 163 citations · Full text
Life Sciences, Biochemistry, Medicinal Chemistry +17
Aminopyridine-Based c-Jun N-Terminal Kinase Inhibitors with Cellular Activity and Minimal Cross-Kinase Activity
Bruce G. Szczepankiewicz, Christi Kosogof, Lissa T.J. Nelson et al. · Journal of Medicinal Chemistry · 2006 · 160 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +15
Discovery of Potent, Selective, Orally Bioavailable Stearoyl-CoA Desaturase 1 Inhibitors
Gang Liu, Jennifer C. Freeman, Bo Liu et al. · Journal of Medicinal Chemistry · 2007 · 118 citations · Full text
Life Sciences, Medicinal Chemistry, Pharmacology +17
1–5 of 42